Promyelocytic leukemia-nuclear body formation is an early event leading to retinoic acid-induced differentiation of neuroblastoma cells
Autor: | Camille Ripoll, Fahd Benjelloun, A. Delaune, E. Legrand, Cécile Corbière, Vannier Jp, Marc Vasse |
---|---|
Přispěvatelé: | Université de Caen Normandie (UNICAEN), Normandie Université (NU), Institut Pasteur de la Guyane, Réseau International des Instituts Pasteur (RIIP), Université de Rouen Normandie (UNIROUEN) |
Rok vydání: | 2007 |
Předmět: |
MESH: Neoplasm Proteins
MESH: Signal Transduction MAPK/ERK pathway [SDV]Life Sciences [q-bio] viruses Cellular differentiation Retinoic acid Promyelocytic Leukemia Protein Biochemistry Neuroblastoma chemistry.chemical_compound 0302 clinical medicine MESH: Promyelocytic Leukemia Protein Enzyme Inhibitors Phosphorylation Nuclear protein Extracellular Signal-Regulated MAP Kinases MESH: Extracellular Signal-Regulated MAP Kinases 0303 health sciences Nuclear Proteins virus diseases Cell Differentiation MESH: Transcription Factors MESH: Gene Expression Regulation Neoplastic Neoplasm Proteins 3. Good health Gene Expression Regulation Neoplastic MESH: Enzyme Inhibitors 030220 oncology & carcinogenesis [SDE]Environmental Sciences Signal transduction Signal Transduction medicine.drug MESH: Cell Differentiation medicine.medical_specialty MESH: Cell Line Tumor education Tretinoin Biology Models Biological 03 medical and health sciences Cellular and Molecular Neuroscience Promyelocytic leukemia protein Keratolytic Agents MESH: Keratolytic Agents Cell Line Tumor MESH: Cell Proliferation Internal medicine medicine Humans MESH: Tumor Suppressor Proteins MESH: Cell Nucleus Structures Cell Proliferation 030304 developmental biology MESH: Tretinoin MESH: Humans MESH: Phosphorylation Tumor Suppressor Proteins MESH: Models Biological medicine.disease MESH: Neuroblastoma Cell Nucleus Structures Endocrinology chemistry Cancer research biology.protein MESH: Nuclear Proteins Transcription Factors |
Zdroj: | Journal of Neurochemistry Journal of Neurochemistry, Wiley, 2007, 104 (1), pp.071106220615005-???. ⟨10.1111/j.1471-4159.2007.05019.x⟩ |
ISSN: | 1471-4159 0022-3042 |
DOI: | 10.1111/j.1471-4159.2007.05019.x |
Popis: | International audience; Neuroblastoma is one of the most common cancers in children. Neuroblastoma differentiation is linked to the presence of the promyelocytic leukemia (PML) protein. Retinoic acid, a powerful differentiation-inducer in vitro, is a potent agent for the treatment of neuroblastoma. Using two different human neuroblastoma cell lines, SH-SY5Y and LA-N-5, we show here that PML protein leads to the formation of nuclear bodies (PML-NB) after only 1 h of retinoic acid treatment and that this formation is mediated by the extracellular signal-regulated kinase (ERK) pathway. Inhibition of protein kinase C also leads to formation of PML-NB via the ERK pathway. Both sumoylation and phosphorylation of PML in an ERK-dependent pathway are also required for formation of PML-NB. Finally, we show that PML-NB formation in neuroblastoma cells is associated with neurite outgrowth. These results support the proposal that the formation of PML-NB is correlated with the differentiation of neuroblastoma cells. |
Databáze: | OpenAIRE |
Externí odkaz: |